Chandramoolika rhizome gélules
Food supplement declared in France, declaration No 2024-3-1661, decision dated 29 March 2024
Chandramoolika rhizome gélules, from SAMSKARA, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Kaempferia galanga 1,500 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- SAMSKARA
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1500 mg
- Directions for use
- 1 à 2 gélules 3 fois par jour avec un verre d'eau.
Declaration 138427, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Kaempferia galanga L. | Rhizome | Poudre (de plantes séchées ou broyées) | 1,500 mg |
Additives
E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Demandez l'avis de votre thérapeute.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Chandramoolika rhizome gélules: composition and regulation”, https://compoatlas.com/en/supplements/products/138427-chandramoolika-rhizome-gelules, updated 15 November 2026.